✨ Your Portfolio is fetched and updated from zerodha.
Micro Miscellaneous
Market Cap
₹21 Cr.
P/E
214.51
  • Natural Biocon (I)
  • Jaipan Industries
  • Lypsa Gems
FAQs on Natural Biocon (India) Ltd. Shareprice

Natural Biocon (I) has given lower returns compared to its competitors.
Natural Biocon (I) has grown at ~-23.03% over the last 4yrs while peers have grown at a median rate of 12.0%

Natural Biocon (I) is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA.
Latest PE of Natural Biocon (I) is 214, while 3 year average PE is 174.
Also latest EV/EBITDA of Natural Biocon (I) is 208 while 3yr average is 254.

Growth Table
  • Natural Biocon (India) Ltd.
  • Jaipan Industries
  • Lypsa Gems
Balance Sheet
  • Natural Biocon (India) Ltd.
  • Jaipan Industries
  • Lypsa Gems
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Natural Biocon (India) Ltd.
  • Jaipan Industries
  • Lypsa Gems
Cash Flow
  • Natural Biocon (India) Ltd.
  • Jaipan Industries
  • Lypsa Gems
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Natural Biocon (India) Ltd.
  • Jaipan Industries
  • Lypsa Gems
Quarterly Results
  • Natural Biocon (India) Ltd.
  • Jaipan Industries
  • Lypsa Gems
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
FAQs on Natural Biocon (India) Ltd. Financials

Natural Biocon (I) balance sheet is weak and might have solvency issues

Yes, The debt of Natural Biocon (I) is increasing.
Latest debt of Natural Biocon (I) is ₹0.24 Crs as of Mar-25.
This is greater than Mar-24 when it was -₹0.12 Crs.

The profit is oscillating.
The profit of Natural Biocon (I) is ₹0.15 Crs for Mar 2024, ₹0.18 Crs for Mar 2023 and ₹0.07 Crs for Mar 2022

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Natural Biocon (I) latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Accounts Receivable

Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech